Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home
 


Online Report Subscribers, Click Here
Pricing and Ordering Information

U.S. Markets for Interventional Cardiology Products
Report #A208 - February 2010
323 Pages - 86 Exhibits - 18 Company Profiles


Every 25 seconds someone in the U.S. will suffer a coronary event, and every 60 seconds someone will die from such an event. In the next decade, the number of people living in the U.S. who have heart conditions is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic disorders such as cardiovascular disease, diabetes, and obesity. Currently, nearly 18 million adults age 20 or older in the U.S. suffer from coronary heart disease (CHD), which is the single largest cause of death in the U.S. and also is the greatest cause of premature and permanent disability in the labor force; CHD is responsible for more than 50% of all cardiovascular events in men and women younger than age 75, and for 1 out of every 6 deaths.

Interventional cardiologists utilize a variety of catheter-based tools for the diagnosis and treatment of heart vessel occlusions and heart defects. In 2008, approximately 6.5 million diagnostic and therapeutic interventional cardiology procedures were performed in the U.S., generating nearly $4.7 billion in corresponding product sales. It is expected that the number of interventional cardiology procedures performed in the U.S. will climb to approximately 8.1 million in the year 2013. During this same period, sales of interventional cardiology products are projected to increase at a compound annual rate of 7.5%, reaching nearly $6.7 billion in the year 2013.

This dynamic, new report from Medtech Insight includes analyses of products, current and emerging markets, competitors, and opportunities for suppliers of interventional cardiology devices to the U.S.

Covered topics in this report include heart disease/disorder statistics and technologies and devices for atherectomy, coronary stenting, chronic total occlusion crossing, coronary angiography, drug-eluting balloon angioplasty, guidewire-based physiologic intravascular stenosis assessment, intracardiac echocardiography, intravascular ultrasound, percutaneous transluminal coronary angioplasty, thrombectomy, transcatheter septal defect repair, and vascular access site closure.

Ordering Information

Title

 Report# Publication
Date		 List Price

U.S. Markets for Interventional Cardiology Products

A208

February 2010

$4,750
Order Online:
Single User only (Please call for corporate subscription pricing)		 PDF Only

Print versions of Reports are available upon request for an additional fee.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

 

EXECUTIVE SUMMARY

i.    Diagnostic Interventional Cardiology Procedures and Products

a.   Coronary Angiography

b.   Guidewire-Based Physiologic Intravascular Stenosis Assessment

c.   Intracardiac Echocardiography

d.   Intravascular Ultrasound

ii.    Therapeutic Interventional Cardiology Procedures and Products

a.   Percutaneous Transluminal Coronary Angioplasty

b.   Coronary Stenting

c.   Atherectomy

d.   Chronic Total Occlusion Crossing

e.   Drug-Eluting Balloon Angioplasty

f.    Thrombectomy

g.   Transcatheter Septal Defect Repair

h.   Vascular Access Site Closure

iii.   Methodology

 

Exhibit ES-1:    Interventional Cardiology, Combined Procedure Volumes Forecast, 2008-2013

Exhibit ES-2:    Interventional Cardiology Products, Combined Market Forecast, 2008-2013

Exhibit ES-3:    Diagnostic Interventional Cardiology, Procedure Volumes Forecast, 2008-2013

Exhibit ES-4:    Diagnostic Interventional Cardiology Products, Market Forecast, 2008-2013

Exhibit ES-5:    Coronary Angiography Devices, Market Forecast, 2008-2013

Exhibit ES-6:    Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2008-2013

Exhibit ES-7:    Intracardiac Echocardiography Catheters, Market Forecast, 2008-2013

Exhibit ES-8:    Intravascular Ultrasound Catheters, Market Forecast, 2008-2013

Exhibit ES-9:    Therapeutic Interventional Cardiology, Procedure Volumes Forecast, 2008-2013

Exhibit ES-10:  Therapeutic Interventional Cardiology Products, Market Forecast, 2008-2013

Exhibit ES-11:  Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2008-2013

Exhibit ES-12:  Coronary Stent Systems, Market Forecast, 2008-2013

Exhibit ES-13:  Atherectomy Systems, Market Forecast, 2008-2013

Exhibit ES-14:  Dedicated Chronic Total Occlusion Crossing Systems, Market Forecast, 2008-2013

Exhibit ES-15:  Drug-Eluting Balloon Angioplasty Systems, Market Forecast, 2008-2013

Exhibit ES-16:  Thrombectomy Systems, Market Forecast, 2008-2013

Exhibit ES-17:  Transcatheter Septal Defect Repair Devices, Market Forecast, 2008-2013

Exhibit ES-18:  Vascular Access Site Closure Devices, Market Forecast, 2008-2013

 

1. HEART DISEASE OVERVIEW

1.1 The Heart and Circulatory System

1.2 Selected Heart Diseases/Disorders

1.2.1 Coronary Heart Disease

1.2.1.1 Atherosclerosis

1.2.1.2 Angina Pectoris

1.2.1.3 Myocardial Infarction

1.2.2 Hypertension

1.2.2.1 Systolic and Diastolic Pressures

1.2.2.2 Prehypertension

1.2.3 Cardiomyopathy

1.2.3.1 Dilated Cardiomyopathy

1.2.3.2 Hypertrophic Cardiomyopathy

1.2.3.3 Restrictive Cardiomyopathy

1.2.4 Congenital Heart Defects

1.2.4.1 Ventricular Septal Defects

1.2.4.2 Atrial Septal Defects

1.2.4.3 Patent Ductus Arteriosus

1.2.5 Heart Failure

1.2.5.1 Disease Development

1.2.5.2 Ejection Fraction Reduction

1.2.5.3 Classification/Staging Systems

 

Exhibit 1-1:      Cross-Section Diagram of the Heart

Exhibit 1-2:      Statistics for Selected Coronary Heart Disease Risk Factors

Exhibit 1-3:      Standard Angina Pectoris Classification

Exhibit 1-4:      Angina Pectoris, Selected Statistics

Exhibit 1-5:      Myocardial Infarction, Selected Statistics

Exhibit 1-6:      Percentage of Adults Who Have Been Told They Have High Blood Pressure, by State

Exhibit 1-7:      Hypertension, Selected Statistics

Exhibit 1-8:      Cardiomyopathy, Selected Statistics

Exhibit 1-9:      Congenital Heart Defects, Selected Statistics

Exhibit 1-10:    Summary, New York Heart Association Heart Failure Classification System

Exhibit 1-11:    Summary, American College of Cardiology/American Heart Association Heart Failure Staging System

Exhibit 1-12:    Heart Failure, Selected Statistics

 

2. DIAGNOSTIC INTERVENTIONAL CARDIOLOGY PROCEDURES AND PRODUCTS

2.1 Coronary Angiography

2.1.1 Procedures/Technologies

2.1.2 Products

2.1.3 Market Forecast

2.1.4 Competitors

2.2 Guidewire-Based Physiologic Intravascular Stenosis Assessment

2.2.1 Procedures/Technologies

2.2.2 Products

2.2.3 Market Forecast

2.2.4 Competitors

2.3 Intracardiac Echocardiography

2.3.1 Procedures/Technologies

2.3.2 Products

2.3.3 Market Forecast

2.3.4 Competitors

2.4 Intravascular Ultrasound

2.4.1 Procedures/Technologies

2.4.2 Products

2.4.3 Market Forecast

2.4.4 Competitors

 

Exhibit 2-1:      Diagnostic Interventional Cardiology, Combined Procedure Volumes Forecast, 2008-2013

Exhibit 2-2:      Diagnostic Interventional Cardiology Products, Combined Market Forecast, 2008-2013

Exhibit 2-3:      Coronary Angiography, Procedure Volumes Forecast, 2008-2013

Exhibit 2-4:      2010, Selected Angiography Catheters

Exhibit 2-5:      2010, Selected Diagnostic Guidewires

Exhibit 2-6:      2010, Selected Introducers/Sheaths

Exhibit 2-7:      Coronary Angiography Devices, Market Forecast, 2008-2013

Exhibit 2-8:      2009, Coronary Angiography Devices Market, Share by Supplier

Exhibit 2-9:      Guidewire-Based Physiologic Intravascular Stenosis Assessment, Procedure Volumes Forecast, 2008-2013

Exhibit 2-10:    2010, Selected Guidewires for Physiologic Intravascular Stenosis Assessment

Exhibit 2-11:    Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2008-2013

Exhibit 2-12:    2009, Physiologic Intravascular Stenosis Assessment Guidewires Market, Share by Supplier

Exhibit 2-13:    Intracardiac Echocardiography, Procedure Volumes Forecast, 2008-2013

Exhibit 2-14:    2010, Selected Intracardiac Echocardiography Catheters

Exhibit 2-15:    Intracardiac Echocardiography Catheters, Market Forecast, 2008-2013

Exhibit 2-16:    2009, Intracardiac Echocardiography Catheters Market, Share by Supplier

Exhibit 2-17:    Intravascular Ultrasound, Procedure Volumes Forecast, 2008-2013

Exhibit 2-18:    2010, Selected Intravascular Ultrasound Catheters

Exhibit 2-19:    Intravascular Ultrasound Catheters, Market Forecast, 2008-2013

Exhibit 2-20:    2009, Intravascular Ultrasound Catheters Market, Share by Supplier

 

3. THERAPEUTIC INTERVENTIONAL CARDIOLOGY PROCEDURES AND PRODUCTS

3.1 Percutaneous Transluminal Coronary Angioplasty

3.1.1 Procedures/Technologies

3.1.1.1 Approaches

3.1.1.2 Complications/Efficacy

3.1.1.3 Procedure Volumes Forecast

3.1.2 Products

3.1.2.1 Balloon Catheters

3.1.2.2 Guiding Catheters

3.1.2.3 Guidewires

3.1.2.4 Introducers/Sheaths

3.1.2.5 Accessories

3.1.3 Market Forecast

3.1.4 Competitors

3.2 Coronary Stenting

3.2.1 Procedures/Technologies

3.2.1.1 Stent Materials, Coatings/Surfaces, and Anti-Restenosis Agents

3.2.1.2 Stent Deployment

3.2.1.3 Indications

3.2.1.4 Complications/Efficacy

3.2.1.5 Procedure Volumes Forecast

3.2.2 Products

3.2.3 Market Forecast

3.2.4 Competitors

3.3 Atherectomy

3.3.1 Procedures/Technologies

3.3.2 Products

3.3.3 Market Forecast

3.3.4 Competitors

3.4 Chronic Total Occlusion Crossing

3.4.1 Procedures/Technologies

3.4.2 Products

3.4.3 Market Forecast

3.3.4 Competitors

3.5 Drug-Eluting Balloon Angioplasty

3.5.1 Procedures/Technologies

3.5.2 Products

3.5.3 Market Forecast

3.6 Thrombectomy

3.6.1 Procedures/Technologies

3.6.2 Products

3.6.3 Market Forecast

3.6.4 Competitors

3.7 Transcatheter Septal Defect Repair

3.7.1 Procedures/Technologies

3.7.1.1 Atrial Septal Defect Repair

3.7.1.2 Patent Ductus Arteriosus Repair

3.7.1.3 Ventricular Septal Defect Repair

3.7.1.4 Procedure Volumes Forecast

3.7.2 Products

3.7.3 Market Forecast

3.7.4 Competitors

3.8 Vascular Access Site Closure Devices

3.8.1 Procedures/Technologies

3.8.2 Products

3.8.3 Market Forecast

3.8.4 Competitors

 

Exhibit 3-1:      Therapeutic Interventional Cardiology, Combined Procedure Volumes Forecast, 2008-2013

Exhibit 3-2:      Therapeutic Interventional Cardiology Products, Combined Market Forecast, 2008-2013

Exhibit 3-3:      Percutaneous Transluminal Coronary Angioplasty/Coronary Stenting, Procedure Volumes Forecast, 2008-2013

Exhibit 3-4:      2010, Selected Percutaneous Transluminal Coronary Angioplasty Balloon Catheters

Exhibit 3-5:      2010, Selected Guiding Catheters for Coronary Interventions

Exhibit 3-6:      2010, Selected Guidewires for Coronary Interventions

Exhibit 3-7:      2010, Selected Introducers/Sheaths for Coronary Interventions

Exhibit 3-8:      2010, Selected Inflation Devices for Coronary Interventions

Exhibit 3-9:      Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2008-2013

Exhibit 3-10:    2009, Percutaneous Transluminal Coronary Angioplasty Devices Market, Share by Supplier

Exhibit 3-11:    2010, Selected Anti-Restenosis Agents

Exhibit 3-12:    Coronary Stenting, Procedure Volumes Forecast, 2008-2013

Exhibit 3-13:    2010, Selected Coronary Stents

Exhibit 3-14:    Coronary Stent Systems, Market Forecast, 2008-2013

Exhibit 3-15:    2009, Coronary Stent Systems Market, Share by Supplier

Exhibit 3-16:    Atherectomy, Procedure Volumes Forecast, 2008-2013

Exhibit 3-17:    2010, Selected Atherectomy Systems

Exhibit 3-18:    Atherectomy Systems, Market Forecast, 2008-2013

Exhibit 3-19:    2009, Atherectomy Systems Market, Share by Supplier

Exhibit 3-20:    Chronic Total Occlusion Crossing,Procedure Volumes Forecast, 2008-2013

Exhibit 3-21:    2010, Selected Chronic Total Occlusion Crossing Devices

Exhibit 3-22:    Dedicated Chronic Total Occlusion Crossing Systems, Market Forecast, 2008-2013

Exhibit 3-23:    Drug-Eluting Balloon Angioplasty, Procedure Volumes Forecast, 2008-2013

Exhibit 3-24:    Drug-Eluting Balloon Angioplasty Systems, Market Forecast, 2008-2013

Exhibit 3-25:    Thrombectomy, Procedure Volumes Forecast, 2008-2013

Exhibit 3-26:    2010, Selected Thrombectomy Systems

Exhibit 3-27:    Thrombectomy Systems, Market Forecast, 2008-2013

Exhibit 3-28:    2009, Thrombectomy Systems Market, Share by Supplier

Exhibit 3-29:    Transcatheter Septal Defect Repair, Procedure Volumes Forecast, 2008-2013

Exhibit 3-30:    2010, Selected Transcatheter Septal Defect Repair Devices

Exhibit 3-31:    Transcatheter Septal Defect Repair Devices, Market Forecast, 2008-2013

Exhibit 3-32:    2009, Transcatheter Septal Defect Repair Devices Market, Share by Supplier

Exhibit 3-33:    Vascular Access Site Closure, Procedure Volumes Forecast, 2008-2013

Exhibit 3-34:    2010, Selected Vascular Access Site Closure Devices

Exhibit 3-35:    Vascular Access Site Closure Devices, Market Forecast, 2008-2013

Exhibit 3-36:    2009, Vascular Access Site Closure Devices Market, Share by Supplier

 

4. COMPANY PROFILES

4.1       Abbott Laboratories

4.2       AGA Medical/AGA Medical Holdings, Inc.

4.3       Arrow International/Teleflex, Inc.

4.4       Boston Scientific Corporation

4.5       B. Braun Melsungen AG

4.6       Cordis Corporation/Johnson & Johnson

4.7       FlowCardia, Inc.

4.8       InSitu Technologies, Inc.

4.9       MEDRAD Interventional Possis/Bayer HealthCare/Bayer Group

4.10     Medtronic, Inc.

4.11     Merit Medical Systems, Inc.

4.12     NMT Medical, Inc.

4.13     OrbusNeich

4.14     Spectranetics Corporation

4.15     St. Jude Medical

4.16     Terumo Medical Corporation/Terumo Corporation

4.17     Vascular Solutions, Inc.

4.18     Volcano Corporation

 

appendix:  company listing

 

 

To order reports or obtain information about special pre-publication offers from within the U.S., contact sales@medtechinsight.com. From outside the U.S., contact internationalsales@medtechinsight.com. You can also call 1.949.453.0071 (or toll-free within the U.S. at 1.888.290.2225) or fax 1.949.453.0072.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home